STOCK TITAN

Milestone Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Milestone Pharmaceuticals Inc. to participate in fireside chat at H.C. Wainwright 25th Annual Global Investment Conference.
Positive
  • Milestone Pharmaceuticals Inc. will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference on September 12, 2023 at 9:00 a.m. ET.
Negative
  • None.

MONTREAL and CHARLOTTE, N.C., Sept. 5, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that members of its management team will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 9:00 a.m. ET.

A live webcast of the fireside chat can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the fireside chat will be available on the same website for approximately 90 days following the presentation.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone's lead product candidate etripamil recently completed its Phase 3 clinical-stage program for the treatment of paroxysmal supraventricular tachycardia (PSVT) and is in a Phase 2 proof-of-concept trial for the treatment of patients with atrial fibrillation with rapid ventricular rate (AFib-RVR). Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow Milestone on Twitter at @MilestonePharma.

Contact

David Pitts
Argot Partners
212-600-1902
milestone@argotpartners.com

Cision View original content:https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-the-hc-wainwright-25th-annual-global-investment-conference-301916144.html

SOURCE Milestone Pharmaceuticals, Inc.

FAQ

What event is Milestone Pharmaceuticals Inc. participating in?

Milestone Pharmaceuticals Inc. is participating in the H.C. Wainwright 25th Annual Global Investment Conference.

When is the fireside chat taking place?

The fireside chat is taking place on September 12, 2023 at 9:00 a.m. ET.

Where can I access the live webcast of the fireside chat?

The live webcast can be accessed on Milestone Pharmaceuticals Inc.'s website at www.milestonepharma.com.

How long will the archived replay of the fireside chat be available?

The archived replay will be available on the same website for approximately 90 days following the presentation.

Milestone Pharmaceuticals Inc. Common Shares

NASDAQ:MIST

MIST Rankings

MIST Latest News

MIST Stock Data

78.84M
53.27M
0.69%
56.94%
0.84%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
MONTREAL